|
[1]
|
王忠诚. 王忠诚神经外科学[M]. 武汉: 湖北科学技术出版社, 2005: 620.
|
|
[2]
|
Rey, J.A., Bello, M.J., de Campos, J.M., et al. (1986) A Case of Pituitary Adenoma with 58 Chromosomes. Cancer Genetics and Cytogenetics, 23, 171-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Roelfsema, F., Biermasz, N.R. and Pereira, A.M. (2012) Clinical Factors Involved in the Recurrence of Pituitary Adenomas after Surgical Remission: A Structured Review and Meta-Analysis. Pituitary, 15, 71-83. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Day, P.F., Loto, M.G., Glerean, M., et al. (2016) Incidence and Prevalence of Clinically Relevant Pituitary Adenomas: Retrospective Cohort Study in a Health Management Organization in Buenos Aires, Argentina.
|
|
[5]
|
Yang, W. (2011) Progress on Hypoxic Regulatory Factor miR-210. Chinese Journal of Pathophysiology, 27, 813.
|
|
[6]
|
杨巍. 乏氧调控因子miR-210的研究进展[J]. 中国病理生理杂志, 2011, 27(4): 813.
|
|
[7]
|
Giannakakis, A., Sandaltzopoulos, R., Greshock, J., et al. (2007) miR-210 Links Hypoxia with Cell Cycle Regulation and Is Deleted in Human Epithelial Ovarian Cancer. Cancer Biology & Therapy, 7, 255. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fasanaro, P., Alesandra, Y., Stefano, V., et al. (2008) MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3. Journal of Biological Chemistry, 283, 15878- 15883. [Google Scholar] [CrossRef]
|
|
[9]
|
Gee, H.E., Camps, C., Buffa, F.M., Patiar, S., Winter, S.C., Betts, G., Homer, J., Corbridge, R., Cox, G., West, C.M., Ragoussis, J. and Harris, A.L. (2010) hsa-mir-210 Is a Marker of Tumor Hypoxia and a Prognostic Factor in Head and Neck Cancer. Cancer, 116, 2148-2158. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ho, A.S., Huang, X., Cao, H., Christman-Skieller, C., Bennewith, K., Le, Q.T. and Koong, A.C. (2010) Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. Translational Oncology, 3, 109-113. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
di Martino, E., Taylor, C.F., Roulson, J.A. and Knowles, M.A. (2013) An Integrated Genomic, Transcriptional and Protein Investigation of FGFRL1 as a Putative 4p16.3 Deletion Target in Bladder Cancer. Genes Chromosomes Cancer, 52, 860-871. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Schild, C. and Trueb, B. (2005) Aberrant Expression of FGFRL1, a Novel FGF Receptor, in Ovarian Tumors. International Journal of Molecular Medicine, 16, 1169-1173. [Google Scholar] [CrossRef]
|
|
[13]
|
徐川, 张怀壁, 康继辉, 等. miRNA在PRL型垂体瘤患者血清中的表达[J]. 世界中西医结合杂志, 2015(4): 543-548.
|
|
[14]
|
Palumbo, T., Faucz, F.R., Azevedo, M., et al. (2013) Functional Screen Analysis Reveals miR-26b and miR-128 as Central Regulators of Pituitary Somatomammotrophic Tumor Growth through Activation of PTEN-AKT Pathway. Oncogene, 32, 1651-6459. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Tsuchiya, S., Fujiwara, T., Sato, F., Shimada, Y., Tanaka, E., Sakai, Y., Shimizu, K. and Tsujimoto, G. (2011) MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-Like 1 (FGFRL1). Journal of Biological Chemistry, 286, 420-428. [Google Scholar] [CrossRef]
|
|
[16]
|
Amaral, F.C., Torres, N., Saggioro, F., et al. (2009) MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors. The Journal of Clinical Endocrinology & Metabolism, 94, 320-323. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Li, S., Yang, J., Wang, J., et al. (2018) Down-Regulation of miR-210-3p Encourages Chemotherapy Resistance of Renal Cell Carcinoma via Modulating ABCC1. Cell & Bioscience, 8, 9. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Morita, K., Takano, K., Yasufuku-Takano, J., et al. (2008) Expression of Pituitary Tumour-Derived, N-Terminally Truncated Isoform of Fibroblast Growth Factor Receptor 4 (ptd-FGFR4) Correlates with Tumour Invasiveness But Not with G-Protein Alpha Subunit (Gsp) Mutation in Human GH-Secreting Pituitary Adenomas. Clinical Endocrinology, 68, 435-441.
|